Mark Alfonso

Title: The Innovative Contributions of Mark Alfonso

Introduction

Mark Alfonso is a notable inventor based in Easton, Connecticut, who has made significant contributions to the field of transdermal drug delivery systems. With a total of five patents to his name, Alfonso has focused on developing effective methods for treating various medical conditions through innovative delivery devices.

Latest Patents

Among his latest patents, the "Loratadine transdermal device and methods" stands out. This invention provides a transdermal delivery device designed to effectively treat seasonal allergic rhinitis and chronic idiopathic urticaria in humans. Another significant patent is the "Terazosin transdermal device and methods," which outlines a method for treating benign prostatic hypertension in humans. This method involves administering amorphous terazosin via a transdermal formulation, which is applied to the skin and maintained in contact for an extended period, typically between 24 hours to 8 days.

Career Highlights

Throughout his career, Mark Alfonso has worked with reputable companies such as Euro-Celtique S.A. and Purdue Pharma L.P. His experience in these organizations has contributed to his expertise in the development of pharmaceutical innovations.

Collaborations

Alfonso has collaborated with talented individuals in the field, including Lino Tavares and Ihor Shevchuk. These partnerships have likely enhanced his work and led to further advancements in his inventions.

Conclusion

Mark Alfonso's contributions to transdermal drug delivery systems exemplify his commitment to innovation in the medical field. His patents reflect a dedication to improving patient care through effective treatment methods.